Medical News

RSS

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.

4 Nov 2004

Study of infection prevention therapy for premature babies

Whether donated human antibodies can protect premature babies from a common and potentially dangerous bacterial infection is under study at the Medical College of Georgia Children’s Medical Center.

4 Nov 2004

Need to belong influences adolescent workplace drug use

In the high-pressure atmosphere of the building and construction industry, adolescent workers are highly susceptible to indulging in work related drug and alcohol use.

4 Nov 2004

Mumps cases amongst young adults continue to increase

Following a continued increase in cases of mumps amongst teenagers and young adults in recent years, the Health Protection Agency’s local teams have been working with schools and universities where outbreaks have taken place, to ensure that students are vaccinated.

4 Nov 2004

FDA fast tracks investigational anti-cancer drug, phenoxodiol

Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, Fast Track status for its intended use in patients with recurrent ovarian cancer.

4 Nov 2004

Research suggests that children with severe malaria may not be as badly dehydrated as was previously thought

Every year around a million people, mainly small children, die of malaria. Dehydration is thought to contribute to fatal cases of the disease and, hence, doctors often give fluids to treat very ill children.

4 Nov 2004

The Bush Medicare Prescription has changed the identity of medical oncology

Under previous law, Medicare covered chemotherapy as well as radiation treatment for cancer patients, but did not pay for oral-dose anti-cancer drugs, unless they were available in both oral and injectable form.

4 Nov 2004

Psoriasis trial enters final stage

Solbec Pharmaceuticals Ltd today announced the successful completion of the first two stages of the Phase I clinical trial of its lead compound, CoramsineTM (SBP002), for the treatment of psoriasis.

4 Nov 2004

Long-term safety of transplanted pig cells to humans confirmed

Living Cell Technologies Limited has published a paper in the November issue of the Journal of Clinical Microbiology which demonstrates the long-term safety of transplanted insulin-producing pig islets in people with type 1 diabetes.

4 Nov 2004

The ethics of face transplants

The ethics of face transplants is among the issues to be discussed at the World Congress of Bioethics, which will be hosted by the University of New South Wales (UNSW) next week.

4 Nov 2004

Genetic mutations could collectively raise bowel cancer risk

Cancer Research UK scientists at the University of Oxford have found that a number of genetic mutations could collectively raise bowel cancer risk, reporting their findings in the journal PNAS.

4 Nov 2004

British Medical Association calls on Health Secretary to deliver tough action to protect the nation's health

The British Medical Association today (4 November 2004) calls on Health Secretary John Reid to deliver tough action to protect the nation's health, as he finalises the White Paper on Public Health for England.

4 Nov 2004

Prolonged breastfeeding helps prevent rheumatoid arthritis

Rheumatoid arthritis (RA), an inflammatory disease of the immune system, is between two and four times more likely to strike women than men.

4 Nov 2004

Study reveals anti-arthritic effects of bee venom

Since ancient times, healers have practiced apitherapy, the use of honeybee products for curative purposes.

4 Nov 2004

Study indicates potential of alendronate and estrogen progression of osteoarthritis

Osteoarthritis (OA) of the knee, a chronic inflammatory disease marked by cartilage degradation and bone abnormalities, is a leading cause of disability among elderly people in the United States.

4 Nov 2004

Amputations due to diabetes can be prevented

Taking a minute or two every day to inspect your feet and observing a few simple rules can make the difference in sparing diabetes patients from a preventable outcome of the disease a foot amputation.

4 Nov 2004

European approval for Taxotere (docetaxel) in prostate cancer

Aventis, part of the sanofi-aventis Group announced today that the European Commission has approved Taxotere (docetaxel) Injection Concentrate for use in combination with prednisone as a treatment for men with androgen-independent (hormone- refractory) metastatic prostate cancer.

4 Nov 2004

Cholesterol-lowering drugs can interact with grapefruit juice and increase the risk of the drugs' potential side-effects

Britain's Medicines and Healthcare Products Regulatory Agency recently issued prescribing advice reminding healthcare professionals that certain cholesterol-lowering drugs, namely Zocor (simvastatin) and Lipitor (atorvastatin), can interact with grapefruit juice and increase the risk of the drugs' potential side-effects.

4 Nov 2004

Generic drugs are still a good buy

A new AARP study found that manufacturers' prices for some generic drugs experienced a rapid rise over the past three years. However, these increases would have added only a few dollars per year to consumers' costs for any one of these products.

4 Nov 2004

NHS chooses Microsoft over Open Source

The NHS has reached a landmark agreement with Microsoft on the renewal of the licensing of its desktop products in line with the OGC's framework agreement with Microsoft.

4 Nov 2004